OneOncology has announced 3 new appointments to its executive team, bringing in experience to clinical, technological, and financial operations.
OneOncology has announced 3 new appointments to its executive team, bringing in experience to clinical, technological, and financial operations. Natalie Dickson, MD, chief medical officer of Tennessee Oncology, has been appointed as chairperson of OneCouncil, the group's clinical advisory and governance board.
"One of the most important attributes to OneOncology's success is physician collboration at a time of an immense knowledge explosion in oncology," said Dickson. "As the Chair of OneCouncil, I'm looking forward to creating a platform and culture for all our physician partners to contribute to, and utilize the success of, the best clinical practices of the best oncology practices in the country."
Reporting directly to the chief exeuctive officer, Garrick Bernstein has been appointed as the chief financial officer of OneOncology. David Stewart has been appointed to chief information officer of the company and will be responsible for defining adn delivering information technology strategy and capabilities across the OneOncology and its partners.
What Will AI in Health Care Look Like in the Future?
July 10th 2025Artificial intelligence (AI) transforms oncology by enhancing clinical decision-making, improving patient outcomes, and shaping future health care training, as discussed by experts at Tennessee Oncology's “Tech Innovations in Community Oncology."
Read More
Practical Considerations for AI in Community Oncology
July 8th 2025Artificial intelligence (AI) transforms oncology by enhancing decision-making, improving patient care, and streamlining operations, while addressing challenges in data accuracy and equity, said speakers at the Tennessee Oncology “Tech Innovations in Community Oncology."
Read More
Without IRA Fix, COA Warns Community Oncology Practices Will Shut Down
June 30th 2025Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the Inflation Reduction Act's impact on Medicare reimbursement, risking patient access to vital cancer treatments.
Read More